We use cookies to personalize your experience, track visits, and analyze traffic. Learn more.
Lived experiences offer invaluable insights into psychedelic care, bridging the gap between clinical science and human experience.
By centering lived experience, we aim to improve safety, outcomes, and ethical standards across research, treatment, and policy.
The first-ever Psychedelic Lived Experiences Summit is part of this mission, bringing diverse voices together to reimagine what truly human-centered psychedelic care can be.
Integrating clinical, scientific, and firsthand perspectives enriches our understanding and enhances the effectiveness of psychedelic treatments.
Yet in a landscape where nuance is often missing, the depth, complexity, and wisdom of lived experience are too easily overlooked.
We’re here to change that. By centering lived experience and embracing diverse perspectives, we aim to shape patient-centered care that moves beyond hype and fear, toward a fuller, more honest understanding of psychedelic healing.
While amplifying patient and participant voices is at the heart of this initiative, our wider goal is to reshape psychedelic care.
By centering it around those with firsthand experience, we ensure treatments are more effective and compassionate.
We aim to make the process of clinical trials and treatments more human-centered, accountable, and informed by the real-world experiences of those they are meant to serve.
Too often, patients, trial participants, and caregivers are excluded from defining what success, safety, and healing should look like in this field.
Our lived experience summit and the initiative behind it, is a response to that exclusion.
By bringing lived experience into direct conversation with clinical and research perspectives, we can build new forms of understanding that neither could reach alone. These insights can lead to safer, more effective, and more meaningful psychedelic treatments.
Sparking more thoughtful, patient-informed dialogue: Recognizing lived experience as essential expertise in research, treatment design, training, and policy through our advocacy.
Building momentum for our future initiatives: Including peer-led aftercare programs, patient–provider communities, resource hubs, ongoing events, and educational offerings.
This is a grassroots effort with a long-term vision: a future where people with lived experience aren’t just included, they’re leading.
A future where lived experience is recognized as essential expertise in psychedelic care, equally valued alongside clinical and scientific knowledge, to ensure treatments are safer, more ethical, and truly effective for those they serve.
To advance patient-centered psychedelic care by elevating lived experience, driving collaboration across disciplines, shaping research and policy, and offering resources that educate, connect, and empower patients, clinicians, researchers, and decision-makers.
Lived experience is expertise: Firsthand experience carries vital knowledge that must inform research, treatment, and policy.
Ethics and integrity: Psychedelic care must center safety, consent, transparency, and accountability at every level.
Grounded hope over hype: We prioritize nuance, responsibility, and real-world outcomes, not sensationalized narratives
Collaboration over silos: Progress happens when scientific, clinical, and lived experience voices work together, not in isolation.
November 21-23, 2025
Join a groundbreaking 3-day virtual event on lived experience in psychedelic care. Patients, therapists, and researchers share insights, challenges, and key lessons to improve patient experiences, clinical outcomes, and quality of life.
We're a team of former patients and clinical trials participants uniting for a common mission to advance lived experience expertise in psychedelic research, treatment, and policy.
Pedram Dara
Founder, director, and host of Psychedelic Lived Experiences Summit
Florence Moureaux
Coordinator for psilocybin therapy in special access program
Becca Kacanda
Coordinator for MDMA-assisted psychotherapy for PTSD clinical trials
Ian Cook
Coordinator for ketamine-assisted therapy clinical treatments
Brad Gagnon
Coordinator for MDMA-assisted therapy in Special Access Program
Cedric Codron
Coordinator for Esketamine (Spravato) clinical treatments
The future of psychedelic care must be built with those who experience it firsthand. Be part of the change by attending our summit, subscribing to our newsletter, or collaborating with us.
✓ Speak at the summit
✓ Share your story
✓ Collaborate with us
✓ Stay connected
Get the latest expert insights and patient perspectives with the Psychedelic Lived Experiences Newsletter. Subscribe for events, news, resources, and more.